Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Back to Search Results

Connection

Search Results to John R Corboy

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Corboy, John

Item TypeName
Academic Article Comparative effectiveness of early natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis.
Academic Article Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Academic Article Multiple sclerosis pathology in the normal and abnormal appearing white matter of the corpus callosum by diffusion tensor imaging.
Academic Article Natalizumab-associated complication? First case of peripheral T cell lymphoma.
Academic Article The association between multiple sclerosis-related fatigue and balance as a function of central sensory integration.
Concept Multiple Sclerosis, Relapsing-Remitting
Academic Article Increased relapse activity for multiple sclerosis natalizumab users who become nonpersistent: a retrospective study.
Academic Article Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study.
Academic Article Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.
Academic Article Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - Commentary.
Academic Article Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis.
Academic Article Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up.
Academic Article Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment.
Academic Article Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Academic Article Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go?
Academic Article Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis-Variations in Real-World Experience.
Academic Article DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial.

Search Criteria
  • Multiple Sclerosis Relapsing Remitting

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)